SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-106207
Filing Date
2018-04-03
Accepted
2018-04-03 16:06:03
Documents
4
Period of Report
2018-03-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d535296d8k.htm 8-K 22736
2 EX-1.1 d535296dex11.htm EX-1.1 220958
3 EX-5.1 d535296dex51.htm EX-5.1 4558
4 EX-10.1 d535296dex101.htm EX-10.1 9562
  Complete submission text file 0001193125-18-106207.txt   259273
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 6503662626
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 18733360
SIC: 2834 Pharmaceutical Preparations